Mahamaya is specializes in manufacturing pesticide formulations and supplying bulk formulations to both Indian agrochemical companies and multinational corporations. It initially focused on importing and registering key pesticide technical molecules that were not produced in India. After conducting extensive product research, the company obtained registrations from the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India. Following successful approvals, it introduced these molecules to the market as technical products and value-added end-use formulations, serving domestic manufacturers as well as global agrochemical brands.
Price Band₹108 - ₹114 |
Dates11 Nov - 13 Nov |
GMP₹0 (0.00%) |
Subscriptions- |
Issue Size₹70.44 Crs |
Mahamaya Lifesciences IPO Objects
- Purchase of Equipment for existing Formulation plant
- Funding capital expenditure towards setting up of a new technical manufacturing plant.
- Construction of Warehouse Building & Purchase of Machinery
- Funding working capital requirement of the Company
- General Corporate purposes
Mahamaya Lifesciences IPO Details
Price Band₹108 - ₹114 |
Listing AtBSE SME |
IPO Issue Type100% Book Built Offer |
Fresh Issue₹64.28 Cr (0.56 Cr Shares) |
Offer For Sale₹6.16 Cr (0.05 Cr Shares) |
Total Issue₹70.44 Cr (0.62 Cr Shares) |
Face Value₹10 per equity share |
Mahamaya Lifesciences IPO Lot Information
| Investor Category | Lot | Shares | Amount | |
|---|---|---|---|---|
| Individual Investor |
Minimum
2
4,800
5,47,200
Maximum
2
4,800
5,47,200
|
|||
| Small HNI |
Minimum
3
7,200
8,20,800
Maximum
3
7,200
8,20,800
|
|||
| Big HNI |
Minimum
4
9,600
10,94,400
|
|||
Mahamaya Lifesciences IPO GMP
The estimated Grey Market Premium of Mahamaya Lifesciences IPO is ₹0 per share (0.00%)
Category Allocation
| Particulars | Allocation |
|---|---|
| QIB | Not more than 50% of Net Offer |
| NII | Not less than 35% of Net Offer |
| Retail | Not less than 15% of Net Offer |
| Market Maker | 309600 EQ Shares |
Mahamaya Lifesciences IPO Financials
| Particulars | Jun-25 | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|---|
| Revenue from Operations | 83.01 | 264.15 | 161.57 | 137.08 |
| Profit after Tax | 4.10 | 12.94 | 5.22 | 3.75 |
| Net Worth | 53.50 | 49.42 | 24.66 | 19.44 |
| Total Borrowing | 57.72 | 58.11 | 54.63 | 24.37 |
| Total Assets | 218.87 | 188.35 | 112.07 | 77.88 |
| NAV per share (in ₹) | 30.11 | 27.82 | 15.38 | 12.13 |
| EPS - Basic (in ₹) | 2.31 | 7.60 | 3.26 | 2.34 |
The financial information presented is on a consolidated basis
Key Performance Indicators
| KPI | Values |
|---|---|
| EBITDA | 9.22% |
| PAT | 4.84% |
| ROE | 34.94% |
| ROCE | 23.15% |
| PE Ratio | 15.00 |
| PB Ratio | 4.10 |
| Mkt Cap (in Crs.) | 266.82 |
- All Ratios are based on Mar 25
- PE, PB, and Post-Issue Market Capitalization are calculated based on the upper price band.
Mahamaya Lifesciences IPO Peer Comparision
| Particulars | Mahamaya Lifesciences Ltd. | Nova Agritech Ltd. | Bhagiradha Ltd. |
|---|---|---|---|
| Total Income (in Crs.) | 267.17 | 296.60 | 449.75 |
| PAT (In Crs.) | 12.94 | 27.42 | 13.86 |
| EPS - Basic | 7.60 | 3.05 | 1.14 |
| NAV per share | 27.82 | 23.76 | 52.61 |
| RONW | 26.19% | 12.47% | 2.03% |
| EBITDA | 9.22% | 15.17% | 9.84% |
| PAT Margin | 4.84% | 9.25% | 3.08% |
| Price to earning (PE) | 15.00 | 16.93 | 247.63 |
- All the information pertains to FY 2024-25
- The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of 20 August for Peers
Mahamaya Lifesciences IPO Peer Comparision
| Particulars | Mahamaya Lifesciences Ltd. |
|---|---|
| Total Income (in Crs.) | 267.17 |
| PAT (In Crs.) | 12.94 |
| EPS - Basic | 7.60 |
| NAV per share | 27.82 |
| RONW | 26.19% |
| EBITDA | 9.22% |
| PAT Margin | 4.84% |
| Price to earning (PE) | 15.00 |
| Nova Agritech Ltd. | Bhagiradha Ltd. |
|---|---|
| 296.60 | 449.75 |
| 27.42 | 13.86 |
| 3.05 | 1.14 |
| 23.76 | 52.61 |
| 12.47% | 2.03% |
| 15.17% | 9.84% |
| 9.25% | 3.08% |
| 16.93 | 247.63 |
- All the information pertains to FY 2024-25
- The PE ratio is calculated using the Upper Price Band for the Issuer and the closing price as of 20 August for Peers
Promoter Details
| Name | Shareholding |
|---|---|
| Krishnamurthy Ganesan | 30.88% |
| Lalitha Krishnamurthy | 23.20% |
| Prashant Krishnamurthy | 23.20% |
| Total | 77.28% |
Management Details
| Name | Designation |
|---|---|
| Krishnamurthy Ganesan | MD |
| Prashant Krishnamurthy | CFO |
Company Details
Name: Mahamaya Lifesciences Limited
Address: Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80, DLF Prime Tower, F – Block, Okhla, Phase – 1 New Delhi – 110020, India.
Number: 1146561474
Email: cs@mahamayalifesciences.com
Website: https://www.mahamayalifesciences.com/
Book Running Lead Managers (BRLMs)
Oneview Corporate
Visit WebsiteRTAs
KFin Technologies
Visit WebsiteFrequently Asked questions?
Find answers to common questions that come in your mind related to IPO.
Mahamaya Lifesciences IPO is a SME IPO having an issue size of Rs. ₹70.44 Crs. Mahamaya Lifesciences IPO is priced at ₹108 - ₹114 per share. The issue opens on 11 Nov 25 and closes on 13 Nov 25.
Mahamaya Lifesciences IPO opens on 11 Nov 25 and closes on 13 Nov 25.
The estimated Grey Market Premium of Mahamaya Lifesciences IPO is ₹0 per share (0.00%).
The minimum lot size of Mahamaya Lifesciences IPO is 2400 shares & the minimum application amount is Rs. 273600.
The allotment date of Mahamaya Lifesciences IPO is 14 Nov 25.
The listing date of Mahamaya Lifesciences IPO is 18 Nov 25.
Mahamaya Lifesciences IPO is subscribed -.
Mahamaya Lifesciences IPO is priced at ₹108 - ₹114 per share.
Click the allotment link on Mahamaya Lifesciences IPO page of IPO360.
- Go to Kite App → Tap on Bids → Tap on IPO
- Select the IPO → Tap on apply → Enter UPI ID
- Enter Qty and Price
- Submit the application
- Approve the UPI Mandate on your UPI app
- Go to Groww App → Stocks Section → Select IPO option
- Select the IPO you want to apply
- Enter your bid details and price
- Enter UPI ID & submit
- Approve the UPI Mandate on your UPI app
- Log in to your bank's net banking portal.
- Navigate to the 'IPO' or 'ASBA' section.
- Select Mahamaya Lifesciences IPO from the list of available IPOs.
- Enter the required details: Bid quantity, Price, DP ID & Client ID, etc
- Submit the application.
- Money will remain blocked till the refund date
We are a one-stop destination for all your IPO needs. Get reliable, accurate, and timely information for all the IPOs in India!